| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 15 | +66.67% | +8.21% | +1.01% | +7.20% | +4.41% | — |
| 14d | 15 | +53.33% | +2.96% | -1.10% | +4.06% | +1.52% | — |
| 30d | 15 | +60.00% | +5.19% | -0.66% | +5.84% | +5.87% | — |
| 60d | 15 | +66.67% | +7.14% | +5.37% | +1.77% | +10.25% | — |
| 90d | 15 | +53.33% | +3.21% | +3.79% | -0.57% | +10.94% | — |
| 180d | 15 | +66.67% | +16.64% | +12.13% | +4.51% | +4.02% | — |
| 1y | 15 | +73.33% | +191.35% | +20.11% | +171.23% | +124.13% | — |
| 2y | 15(11 pending) | +0.00% | -82.91% | +47.68% | -130.59% | -127.86% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 837,000 | — | — | 837,000 | Feb 4, 2026 | Feb 5, 2026 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 675,000 | $0.69 | $467.4K | 1,999,296 | Mar 25, 2025 | Mar 27, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 15,000 | $0.73 | $11.0K | 1,324,296 | Mar 21, 2025 | Mar 24, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 5,416 | $0.73 | $4.0K | 1,309,296 | Mar 20, 2025 | Mar 24, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 9,106 | $0.75 | $6.8K | 1,303,880 | Mar 17, 2025 | Mar 18, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 29,999 | $0.75 | $22.6K | 1,294,774 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 50,000 | $0.72 | $35.8K | 1,264,775 | Mar 13, 2025 | Mar 14, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 47,500 | $0.71 | $33.7K | 1,214,775 | Mar 12, 2025 | Mar 14, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 496,000 | — | — | 496,000 | Feb 4, 2025 | Feb 5, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 5,000 | $1.21 | $6.0K | 142,553 | Dec 31, 2024 | Jan 3, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 10,000 | $1.20 | $12.0K | 137,553 | Dec 30, 2024 | Jan 2, 2025 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 6,888 | $0.89 | $6.1K | 127,553 | Dec 19, 2024 | Dec 20, 2024 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 100,000 | $0.93 | $93.2K | 1,167,275 | Dec 18, 2024 | Dec 20, 2024 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 900 | $5.31 | $4.8K | 1,067,275 | May 25, 2023 | May 26, 2023 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 1,000 | $5.01 | $5.0K | 1,066,375 | May 24, 2023 | May 26, 2023 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 11,856 | $5.63 | $66.7K | 1,065,375 | May 23, 2023 | May 25, 2023 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 330,000 | — | — | 330,000 | Feb 7, 2023 | Feb 9, 2023 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE CEO | 19,188 | $5.13 | $98.4K | 120,665 | Dec 20, 2022 | Dec 21, 2022 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 327,900 | — | — | 327,900 | Feb 15, 2022 | Feb 17, 2022 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 8,000 | $12.13 | $97.0K | 1,053,519 | Dec 13, 2021 | Dec 14, 2021 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASEGRANT Stock grant | 285,800 | — | — | 285,800 | Jul 20, 2021 | Jul 22, 2021 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE President, CEO | 101,477 | — | — | 101,477 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | SALE President, CEO | 32,876 | — | — | 0 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE President, CEO | 32,876 | — | — | 551,776 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | PURCHASE President, CEO | 32,876 | — | — | 551,774 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |
| PRLD PRELUDE THERAPEUTICS INC | SALE President, CEO | 101,477 | — | — | 0 | Sep 29, 2020 | Sep 29, 2020 ↗ | View → |